Loading...
Raily Aesthetic Medicine International Holdings Limited
2135.HK•HKSE
Healthcare
Medical - Care Facilities
HK$0.13
HK$0.001(0.78%)
Raily Aesthetic Medicine International Holdings Limited (2135.HK) Financial Performance & Income Statement Overview
Review Raily Aesthetic Medicine International Holdings Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.26%
↑ 5.26%
Operating Income Growth
16.93%
↑ 16.93%
Net Income Growth
-82.43%
↓ 82.43%
Operating Cash Flow Growth
-25.10%
↓ 25.10%
Operating Margin
-21.67%
↓ 21.67%
Gross Margin
35.36%
↑ 35.36%
Net Profit Margin
-32.90%
↓ 32.90%
ROE
-21.21%
↓ 21.21%
ROIC
-15.41%
↓ 15.41%
Raily Aesthetic Medicine International Holdings Limited (2135.HK) Income Statement & Financial Overview
Review Raily Aesthetic Medicine International Holdings Limited's (2135.HK) income statement with detailed quarterly and annual figures.
| Metric | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $89.81M | $45.90M | $101.96M | $48.79M |
| Cost of Revenue | $58.05M | $29.67M | $61.18M | $29.28M |
| Gross Profit | $31.76M | $16.23M | $40.78M | $19.51M |
| Gross Profit Ratio | $0.35 | $0.35 | $0.40 | $0.40 |
| R&D Expenses | $1.57M | $801000.00 | $0.00 | $0.00 |
| SG&A Expenses | $49.66M | $25.54M | $43.74M | $20.65M |
| Operating Expenses | $51.23M | $32.01M | $43.74M | $20.26M |
| Total Costs & Expenses | $109.28M | $61.68M | $104.92M | $49.53M |
| Interest Income | $0.00 | $326500.00 | $0.00 | $655000.00 |
| Interest Expense | $1.46M | $0.00 | $1.37M | $0.00 |
| Depreciation & Amortization | $13.15M | $3.82M | $13.32M | $3.93M |
| EBITDA | -$6.32M | -$6.29M | $10.36M | $2.79M |
| EBITDA Ratio | -$0.07 | -$0.14 | $0.10 | $0.06 |
| Operating Income | -$19.47M | -$10.11M | -$2.96M | -$1.14M |
| Operating Income Ratio | -$0.22 | -$0.22 | -$0.03 | -$0.02 |
| Other Income/Expenses (Net) | -$10.43M | -$6.00M | $122257.00 | -$260500.00 |
| Income Before Tax | -$29.89M | -$16.11M | -$2.84M | -$1.40M |
| Income Before Tax Ratio | -$0.33 | -$0.35 | -$0.03 | -$0.03 |
| Income Tax Expense | $1.44M | $734500.00 | $1.36M | $650000.00 |
| Net Income | -$29.55M | -$15.10M | -$2.36M | -$1.13M |
| Net Income Ratio | -$0.33 | -$0.33 | -$0.02 | -$0.02 |
| EPS | -$0.07 | -$0.04 | -$0.005 | -$0.003 |
| Diluted EPS | -$0.07 | -$0.04 | -$0.005 | -$0.003 |
| Weighted Avg Shares Outstanding | $480.60M | $417.81M | $480.60M | $417.90M |
| Weighted Avg Shares Outstanding (Diluted) | $480.60M | $417.81M | $480.60M | $417.81M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan